CAMP4 Therapeutics Corporation
CAMPHealthcare|Biotechnology|US
$4.06
+0.34 (+9.14%)
Tangible Book / Share
$1.36
Cash / Share
$1.58
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06247670 Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype | Healthy Volunteers, OTC Deficiency | P1 | Active | 120 | RCT, Double-blind | CMP-CPS-001 |